CIK 0000811641 · Non-accelerated filer<br>Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010382980
- Phone
- 2078782770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- 4 Open-market buy President and CEO bought 9,785 shares at an average $4.97 ($48,588)
- 4 Open-market buy Director bought 3,266 shares at an average $4.76 ($15,554)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 3,530 shares (option exercise)
- 4 Open-market buy Director bought 1,000 shares at $6.32 ($6,320)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Returned to the company Director returned 2,186 shares (to the company)
- 4 Returned to the company Director returned 6,005 shares (to the company)
- 4 Returned to the company Director returned 10,000 shares (to the company)
- 4 Returned to the company Director returned 10,000 shares (to the company)
- 4 Returned to the company Director returned 3,100 shares (to the company)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 2 of 13 · 255 filings